Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT)

Background: IT and TT have improved survival for many pts with mNSCLC. However, the lived experience of these pts is under-studied. We conducted a single centre, qualitative study to understand concerns and supportive care needs of this novel survivor population... Conclusions: Longer term survivors of mNSCLC report significant physical, psychological and functional concerns and unmet needs. Self-management strategies for chronic toxicities, professional psychological services to manage FCP and scan-related anxiety, and tailored information regarding work and financial planning may mitigate these concerns. Future work should examine these issues in a larger population. READ ARTICLE

Journal of Clinical Oncology DOI:10.1200/JCO.2020.38.15_suppl.e24185

Authors: Julia Elizabeth Lai-Kwon, Sarah Heynemann, Jacinthe Flore, Mary Duffy, Renata Kokanovic, Michael Jefford

Real-World OutcomesKirk SmithMay 25, 2020Non-small cell lung cancer (mNSCLC), metastasis, immunotherapy (IT), (IT) or targeted therapy (TT), supportive care